Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits

详细信息    查看全文

• 作者：FeiJun Zhao (1)
  XiaoHong Zhang (2)
  ShuangQuan Liu (3)
  TieBing Zeng (1)
  Jian Yu (4)
  WeiMing Gu (5)
  YueJun Zhang (1)
  Xi Chen (6)
  YiMou Wu (1)
  
• 关键词：Treponema pallidum (Tp) ; membrane protein ; Gpd ; CS ; IL ; 2 ; nucleic acid vaccine
• 刊名：Science China Life Sciences
• 出版年：2013
• 出版时间：February 2013
• 年：2013
• 卷：56
• 期：2
• 页码：174-180
• 全文大小：643KB
• 参考文献：1. Li X W, Lee D K, Chan A S, et al. Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. Biochim Biophys Acta, 2003; 1630: 7-8 CrossRef
  2. Bozkir A, Hayta G, Saka O M. Comparison of biodegradable nanoparticles and multiple emulsions (water-in-oil-in-water) containing influenza virus antigen on the / in vivo immune response in rats. Pharmazie, 2004, 59: 723-25
  3. Fu M L, Ying S C, Wu M, et al. Regulating effects of novel CpG chitosan nanoparticles on immune responses of mice to porcine paratyphoid vaccines. Biomed Environ Sci, 2006; 19: 315-22
  4. Yang Y, Chen J, Li H, et al. Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine. Comp Immunol Microbiol Infect Dis, 2006, 30: 19-2 CrossRef
  5. Zhang H, Cheng C, Zheng M, et al. Enhancement of immunity to an / Escherichia coli vaccine in mice orally inoculated with a fusion gene encoding porcine interleukin 4 and 6. Vaccine, 2007, 25: 7094-101 CrossRef
  6. Tomoyuki I, Yoshitsugu I, Takao N, et al. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis. Invest Ophthalmol Vis Sci, 2000, 41: 4209-215
  7. Zhang W, Yin Z, Liu N, et al. DNA-chitosan nanoparticles improve DNA vaccine-elicited immunity against Newcastle disease virus through shuttling chicken interleukin-2 gene. J Microencapsul, 2010, 27: 693-02 CrossRef
  8. Xu J, Dai W, Wang Z, et al. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae. Clin Vaccine Immunol, 2011, 18: 75-1 CrossRef
  9. Barouch D H, Santra S, Schmitz J E. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science, 2000, 290: 486-92 CrossRef
  10. Zhao F J, Wu Y M, Zhang X H, et al. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2. Human Vaccines, 2011, 7: 1083-089 CrossRef
  11. Zhao F J, Wu Y M, Zhang X H, et al. Eukaryotic expression of outer membrane protein Gpd from treponema pallidum and preliminary studies on its immune response in rabbits. Chin J Microbiol Immunol, 2005, 3: 94-00
  12. Mao H Q, Roy K, Troung-Le V L, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Contr Release, 2001, 70: 399-21 CrossRef
  13. Scherman D, Bessodes M, Cameron B, et al. Application of lipids and plasmid design for gene delivery to mammalian cells. Curr Opin Biotechnol, 1998, 9: 480-85 CrossRef
  14. Wilson G L, Dean B S, Wang G, et al. Nuclear import of plasmid DNA in digitonin-permeabilized cells requires both cytoplasmic factors and specific DNA sequences. J Biol Chem, 1999, 274: 22025-2032 CrossRef
  15. Dauty E, Verkman A S. Actin cytoskeleton as the principal determinant of size-dependent DNA mobility in cytoplasm: a new barrier for non-viral gene delivery. J Biol Chem, 2005, 280: 7823-828 CrossRef
  16. Zhao F J, Wang S P, Zhang X H, et al. Protective efficacy of a treponema pallidum Gpd DNA vaccine vectored by chitosan nanoparticles and fused with interleukin-2. Can J Microbiol, 2012, 58: 117-23 CrossRef
  
• 作者单位：FeiJun Zhao (1)
  XiaoHong Zhang (2)
  ShuangQuan Liu (3)
  TieBing Zeng (1)
  Jian Yu (4)
  WeiMing Gu (5)
  YueJun Zhang (1)
  Xi Chen (6)
  YiMou Wu (1)
  
  1. Pathogenic Biology Institute, School of Medicine, University of South China, Hengyang, 421001, China
  2. Department of Histology and Embryology, School of Medicine, University of South China, Hengyang, 421001, China
  3. The First Affiliated Hospital, University of South China, Hengyang, 421001, China
  4. Department of Experimental Zoology, School of Medicine, University of South China, Hengyang, 421001, China
  5. Skin Diseases and STD Hospital, Shanghai, 200050, China
  6. Centers for Disease Control of Hunan Province, Changsha, 410005, China
  

文摘

Syphilis is a multistage, sexually transmitted disease caused by the spirochete, Treponema pallidum (Tp). A significantly high incidence of syphilis has been reported in several countries, including China, and there is an urgent need for the development of efficacious vaccines against syphilis. DNA vaccines are a major breakthrough in the field of vaccination with several advantages over traditional vaccines. Animal model studies of Tp DNA vaccines have not been reported elsewhere but our previous reports describe the development of a single-gene Tp DNA vaccine and preclinical immunization study. In this study, chitosan (CS) nanoparticles were used as a vector and an interleukin-2 expression plasmid (pIL-2) as an adjuvant to enhance a TpGpd DNA vaccine candidate (pTpGpd) in a rabbit Tp skin challenge model. At week 8 after the first immunization, three rabbits from each group were used to determine cytokine measurements and spleen lymphocyte proliferation assay. pTpGpd in combination with pIL-2 wrapped with CS led to the greatest enhancement of anti-TpGpd antibodies and T-cell proliferation. During infection, levels of anti-TpGpd antibodies and T-cell proliferation were measured. Both the serum special IgG and IL-2, interferon-γ were significantly increased by the co-injection of the IL-2 plasmid compared with the injection of TpGpd DNA alone (P<0.05). Furthermore, IL-2 plasmid coinjection efficiently enhanced the antigen-specific lymphocyte proliferation response. Additionally, the ratios of positive skin lesions and ulcer lesions in groups immunized with pTpGpd were significantly lower than those of the pIL-2, CS or pIL-2 mixed with CS control groups (P<0.001). CS vectored and pIL-2 adjuvanted pTpGpd immunized animals exhibited the lowest rates of positive skin tests (8.33%) and ulcer lesions (4.17%) and the fastest recovery (42 d). These experiments indicate that co-injection of a pIL-2 plasmid with pTpGpd DNA vaccine wrapped with CS can significantly strengthen the long-term stability of immune response during infection, efficiently improve the protective effect against T. pallidum spirochetes infection and attenuate syphilitic lesion development.